Yu Y - Search Results

1

Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.

Jin J, Jin J, Woodfield SE, Patel RH, Jin NG, Shi Y, Liu B, Sun W, Chen X, Yu Y, Vasudevan SA. Jin J, et al. Among authors: yu y. Oncol Rep. 2019 Jan;41(1):143-153. doi: 10.3892/or.2018.6793. Epub 2018 Oct 15. Oncol Rep. 2019. PMID: 30320362 Free PMC article.

2

Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.

Wang Y, Wang L, Guan S, Cao W, Wang H, Chen Z, Zhao Y, Yu Y, Zhang H, Pang JC, Huang SL, Akiyama Y, Yang Y, Sun W, Xu X, Shi Y, Zhang H, Kim ES, Muscal JA, Lu F, Yang J. Wang Y, et al. Among authors: yu y. Sci Rep. 2016 Jan 20;6:19423. doi: 10.1038/srep19423. Sci Rep. 2016. PMID: 26786851 Free PMC article.

3

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment.

Li H, Chen Z, Hu T, Wang L, Yu Y, Zhao Y, Sun W, Guan S, Pang JC, Woodfield SE, Liu Q, Yang J. Li H, et al. Among authors: yu y. Sci Rep. 2016 Sep 30;6:34397. doi: 10.1038/srep34397. Sci Rep. 2016. PMID: 27687684 Free PMC article.

4

Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma.

Mao X, Chen Z, Zhao Y, Yu Y, Guan S, Woodfield SE, Vasudevan SA, Tao L, Pang JC, Lu J, Zhang H, Zhang F, Yang J. Mao X, et al. Among authors: yu y. Oncotarget. 2017 Jan 3;8(1):1555-1568. doi: 10.18632/oncotarget.13657. Oncotarget. 2017. PMID: 27902463 Free PMC article.

5

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.

Bieerkehazhi S, Chen Z, Zhao Y, Yu Y, Zhang H, Vasudevan SA, Woodfield SE, Tao L, Yi JS, Muscal JA, Pang JC, Guan S, Zhang H, Nuchtern JG, Li H, Li H, Yang J. Bieerkehazhi S, et al. Among authors: yu y. Oncotarget. 2017 Jan 3;8(1):1469-1480. doi: 10.18632/oncotarget.13643. Oncotarget. 2017. PMID: 27903968 Free PMC article.

6

Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis.

Chen Z, Wang L, Yao D, Yang T, Cao WM, Dou J, Pang JC, Guan S, Zhang H, Yu Y, Zhao Y, Wang Y, Xu X, Shi Y, Patel R, Zhang H, Vasudevan SA, Liu S, Yang J, Nuchtern JG. Chen Z, et al. Among authors: yu y. Sci Rep. 2016 Dec 19;6:38011. doi: 10.1038/srep38011. Sci Rep. 2016. PMID: 27991505 Free PMC article.

7

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.

Lu J, Guan S, Zhao Y, Yu Y, Woodfield SE, Zhang H, Yang KL, Bieerkehazhi S, Qi L, Li X, Gu J, Xu X, Jin J, Muscal JA, Yang T, Xu GT, Yang J. Lu J, et al. Among authors: yu y. Cancer Lett. 2017 Aug 1;400:61-68. doi: 10.1016/j.canlet.2017.04.022. Epub 2017 Apr 26. Cancer Lett. 2017. PMID: 28455243 Free PMC article.

8

EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma.

Sun W, Rojas Y, Wang H, Yu Y, Wang Y, Chen Z, Rajapakshe K, Xu X, Huang W, Agarwal S, Patel RH, Woodfield S, Zhao Y, Jin J, Zhang H, Major A, Hicks MJ, Shohet JM, Vasudevan SA, Coarfa C, Yang J, Nuchtern JG. Sun W, et al. Among authors: yu y. Oncotarget. 2017 Oct 19;8(55):94780-94792. doi: 10.18632/oncotarget.21933. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212266 Free PMC article.

9

Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma.

Yu Y, Zhao Y, Fan Y, Chen Z, Li H, Lu J, Guo K, Woodfield SE, Vasudevan SA, Yang J, Nuchtern JG. Yu Y, et al. Mol Cancer Ther. 2019 Jun;18(6):1045-1056. doi: 10.1158/1535-7163.MCT-18-0146. Epub 2019 Apr 8. Mol Cancer Ther. 2019. PMID: 30962318 Free PMC article.

10

Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling.

Li H, Yu Y, Zhao Y, Wu D, Yu X, Lu J, Chen Z, Zhang H, Hu Y, Zhai Y, Su J, Aheman A, De Las Casas A, Jin J, Xu X, Shi Z, Woodfield SE, Vasudevan SA, Agarwal S, Yan Y, Yang J, Foster JH. Li H, et al. Among authors: yu x, yu y. Cancer Lett. 2019 Aug 10;457:129-141. doi: 10.1016/j.canlet.2019.05.011. Epub 2019 May 14. Cancer Lett. 2019. PMID: 31100410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37,946 results

Search Page